Article info

other Versions

Download PDFPDF
Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups

Authors

  1. Correspondence to Dr Gabriella Macchia, Radiation Oncology Unit, Gemelli Molise, Campobasso 86100, Molise, Italy; macchiagabriella{at}gmail.com
View Full Text

Citation

Macchia G, Nardangeli A, Laliscia C, et al
Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups

Publication history

  • Received November 17, 2021
  • Accepted February 3, 2022
  • First published February 22, 2022.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.